Should you build or buy Electronic Lab Notebook (ELN)?
An electronic lab notebook replaces paper notebooks for documenting experiments, protocols and results, with search, tagging, version history, electronic signing and audit trails. Research institutions and biotech companies use it to record scientific work, protect intellectual property claims, and, in regulated settings, support GxP and Part 11 compliance.
Buy a validated commercial ELN if records support regulatory submissions or discovery depends on Benchling-style registry and sequence tooling; self-host eLabFTW or openBIS when the need is research documentation and the institution can own hosting and validation.
Build it, buy it, or bridge?
When building makes sense
eLabFTW and openBIS are the two clearest self-build paths here, and both run at real scale in production, not as pilots. A 2026 study documents eLabFTW deployed to 237 users across 32 teams at University Medicine Halle and MLU, generating 4,263 active experiments during an October 2024 to July 2026 rollout. France's CNRS, the largest fundamental science agency in Europe, selected eLabFTW as its recommended ELN for all CNRS laboratories, and Empa has run openBIS as its ELN and LIMS layer since 2020. Both platforms are free and give an institution full data sovereignty, at the cost of a sysadmin to install and maintain the server. AI coding assistants make it faster to extend either platform's plugins, part of why open-source ELNs keep pace with commercial feature sets. Neither ships GxP or Part 11 signing with vendor-provided IQ/OQ/PQ documentation as a validated, out-of-the-box capability; that stays dependent on how your own institution configures and validates the deployment.
When buying makes sense
Buy a validated commercial ELN once records need to support a regulatory submission, or discovery work depends on molecular-biology tooling that a plain notebook does not provide. Benchling differentiates specifically on a biological Registry and sequence tooling that eLabFTW and openBIS do not attempt to replicate, and its Validated Cloud option ships the IQ/OQ documentation regulated teams need. IDBS E-WorkBook and Revvity Signals Notebook target structured development workflows and validated pricing respectively, with Signals published near $1,425 per user per year including IQ/OQ materials. The gap that matters is not features so much as who carries validation responsibility. With a commercial platform, the vendor provides that documentation. With eLabFTW, your own institution writes and owns it, which is standard in academic settings but a real liability question in a regulated biotech. Buy when records feed a regulatory submission, or when Benchling-style registry and sequence tooling is what your science actually needs.
The desk read
Build-versus-buy analysis for Electronic Lab Notebook (ELN) is being written. In the meantime, the framework that drives every B4 call is on the B4 Index page.
Frequently asked
What is an electronic lab notebook (ELN)?
It is the digital record that stands in for a lab notebook in an intellectual property or regulatory dispute. Cliniques and universities weigh it differently from biotech: France's CNRS deployed eLabFTW across all its labs, while a drug discovery team is more likely to need Benchling's registry tooling instead.
Are open-source ELNs like eLabFTW production-ready?
Yes. eLabFTW runs at University Medicine Halle with 237 users across 32 teams, and France's CNRS selected it as the recommended ELN for all its laboratories. It is free to self-host but needs a sysadmin, and full GxP validation is the institution's responsibility, not a vendor's.
When does a lab need a validated commercial ELN instead?
When records support a regulatory submission requiring vendor-provided IQ/OQ/PQ documentation, or when the work depends on Benchling-style molecular-biology registry and sequence tooling that open-source ELNs do not attempt to replicate.
What are the main ELN vendors?
Representative vendors include Benchling, IDBS E-WorkBook. B4 Pro includes the category score and the full vendor list.